Effect of Sofosbuvir-daclatasuvir on Angiogenesis
Launched by SHERIEF ABD-ELSALAM · Aug 23, 2018
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two medications, Daclatasvir and Sofosbuvir, on a process called angiogenesis, which is the formation of new blood vessels. The research focuses on Egyptian patients who have chronic hepatitis C virus (HCV) infection. The goal is to see how these medications might help improve conditions related to HCV.
To be eligible for this study, participants need to have chronic HCV. However, individuals with liver cancer, HIV, hepatitis B, other types of cancer, or those who are pregnant cannot participate. If you join the trial, you will be part of a group that is closely monitored while receiving these medications. The study is currently recruiting participants aged between 65 and 74 years, and it welcomes patients of all genders. This could be an important opportunity for those looking for new treatment options for chronic HCV.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic HCV patients
- Exclusion Criteria:
- • HCC.
- • HIV or HBV.
- • Malignancy.
- • Pregnancy.
About Sherief Abd Elsalam
Sherief Abd-elsalam is a dedicated clinical trial sponsor with extensive expertise in advancing medical research and innovation. Committed to improving patient outcomes, Abd-elsalam oversees the design, implementation, and management of clinical trials across various therapeutic areas. With a strong focus on regulatory compliance and ethical standards, he fosters collaboration between research institutions, healthcare professionals, and regulatory bodies to ensure the successful progression of trials. Abd-elsalam's leadership is characterized by a commitment to scientific integrity and a passion for translating research findings into actionable healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, , Egypt
Patients applied
Trial Officials
Eman h abd El-Razek, Msc
Principal Investigator
Clinical pharmacy Department- Tanta University
Tarek M Mostafa, Ph D
Principal Investigator
Clinical pharmacy Department- Tanta University
Nashwa Shebl, Ph D
Principal Investigator
Hematology and Gastroenterology - Menoufia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials